biosquare
-
HLB Panagene Strengthens Global Presence in In-Vitro Diagnostics at Medlab Middle East 2025Big Tech 2025. 2. 4. 20:43
· HLB Panagene and Biosquare showcase cutting-edge diagnostics at major Middle East exhibition. HLB Panagene, in conjunction with its subsidiary Biosquare, is participating in Medlab Middle East 2025 (Medlab 2025), held at the Dubai World Trade Centre from February 3-6. The company's dedicated booth at the event underscores its strategic initiative to expand its reach within the global in-vitro ..
-
HLB Panagene Expands Diagnostics Portfolio, Targets Global Market with Subsidiary BioSquareBig Tech 2024. 7. 4. 23:17
· HLB Panagene expands precision diagnostics beyond cancer, targeting global market for infections like respiratory diseases with BioSquare's diagnostics. SEOUL, South Korea, July 4, 2024 (IT Times) - HLB Panagene and its subsidiary BioSquare unveiled a strategic plan today to capture the global market for cancer and respiratory diagnostics, estimated to be worth 10 trillion won (approximately $..